Erinc, O.; Yilmaz, O.; Kaya, T.Y.; Algemi, M.; Akarsu, M.
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients. J. Clin. Med. 2025, 14, 4029.
https://doi.org/10.3390/jcm14124029
AMA Style
Erinc O, Yilmaz O, Kaya TY, Algemi M, Akarsu M.
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients. Journal of Clinical Medicine. 2025; 14(12):4029.
https://doi.org/10.3390/jcm14124029
Chicago/Turabian Style
Erinc, Osman, Ozgur Yilmaz, Tacettin Yekta Kaya, Murvet Algemi, and Murat Akarsu.
2025. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients" Journal of Clinical Medicine 14, no. 12: 4029.
https://doi.org/10.3390/jcm14124029
APA Style
Erinc, O., Yilmaz, O., Kaya, T. Y., Algemi, M., & Akarsu, M.
(2025). Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Erectile Dysfunction in Diabetic Patients. Journal of Clinical Medicine, 14(12), 4029.
https://doi.org/10.3390/jcm14124029